Toxic effects of immunosuppressive drugs: Mechanisms and strategies for controlling them

Clinical Chemistry

Volumn 42, Issue 8 SPEC. ISS., 1996, Pages 1316-1321

  Shaw, Leslie M ^a   Kaplan, Bruch ^b   Kaufman, Dixon ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

randomized concentration controlled trial; therapeutic drug monitoring; transplant patients

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID; TACROLIMUS;

CONFERENCE PAPER; DRUG MONITORING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; NEPHROTOXICITY; NEUROTOXICITY; ORGAN TRANSPLANTATION;

EID: 0029817346     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.8.1316     Document Type: Conference Paper

References (11)

1. Morris RE. Mechanisms of action of new immunosuppressive drugs. Kidney Int 1996;49:526-38.
2. Bach JF. The quiet revolution of immunosuppressive therapy. Transplant Proc 1994;26:3093.
3. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984;311:699-705.
4. Terasaki PI, Cecka JM, eds. Clinical transplants 1994. Los Angeles: UCLA Tissue Typing Laboratory, 1995.
5. Bowers LD, Matthews SE. Investigation of the mechanisms of peak broadening observed in the high-performance liquid Chromatographic analysis of cyclosporine. J Chromatogr 1985;333:231-8.
6. Annesley TM, Gicherio DA, Feldkamp CS. The concentration related distribution of cyclosporine in blood. J Clin Immunoassay 1986;9:53-6.
7. Shaw LM, Bowers LD, Demers L, Freeman D, Moyer T, Sanghvi A, et al. Critical issues in CsA monitoring: report of the task force on CsA monitoring. Clin Chem 1987;33:1269-88.
8. Moyer TP, Post GR, Sterioff S, Anderson CF. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood. Mayo Clin Proc 1988;63:241-7.
9. Shaw LM, Yatscoff RW, Bowers LD, Freeman DJ, Jeffery JR, Keown PA, et al. Canadian consensus meeting on CsA monitoring: report of the consensus panel. Clin Chem 1990;36:1841-6.
10. Oellerich M, Armstrong VW, Kahan B, Shaw LM, Holt DW, Yatscoff R, et al. Lake Louise conference on CsA monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 1995;17:642-54.
11. Holt DW, Johnston A, Roberts NB, Tredger JM, Trull AK. Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists Task Force. Ann Clin Biochem 1994;31:420-46.